15-67181442-G-A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_005902.4(SMAD3):c.860G>A(p.Arg287Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R287W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_005902.4 missense
Scores
Clinical Significance
Conservation
Publications
- aneurysm-osteoarthritis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMAD3 | NM_005902.4 | c.860G>A | p.Arg287Gln | missense_variant | Exon 6 of 9 | ENST00000327367.9 | NP_005893.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMAD3 | ENST00000327367.9 | c.860G>A | p.Arg287Gln | missense_variant | Exon 6 of 9 | 1 | NM_005902.4 | ENSP00000332973.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460840Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726726 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:3
The p.R287Q variant (also known as c.860G>A), located in coding exon 6 of the SMAD3 gene, results from a G to A substitution at nucleotide position 860. The arginine at codon 287 is replaced by glutamine, an amino acid with highly similar properties. This variant was reported in individual(s) with Loeys-Dietz syndrome or thoracic aortic aneurysm and dissection, though several papers lacked patient-specific details, and cohort overlap cannot be ruled out (Aubart M et al. PLoS One, 2014 May;9:e96387; Arnaud P et al. Genet Med, 2019 Sep;21:2015-2024; Hostetler EM et al. J Med Genet, 2019 Apr;56:252-260; Solomonica A et al. Am J Cardiol, 2019 Jul;124:313-315; Velchev JD et al. Stem Cell Res, 2022 Oct;64:102932; Ambry internal data). In addition, this variant was determined to be de novo in a fetus with agnathia-otocephaly, which authors speculated may represent the severe end of the disease spectrum (Meier N et al. Mol Genet Genomic Med, 2020 Apr;8:e1178). This missense alteration is located in a region that has a low rate of benign missense variation (Lek M et al. Nature. 2016 Aug 18;536(7616):285-91; DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Firth H.V. et al. 2009. Am.J.Hum.Genet. 84, 524-533 (DOI: dx.doi.org/10/1016/j.ajhg.2009.03.010)). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic.
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 287 of the SMAD3 protein (p.Arg287Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with SMAD3-related conditions (PMID: 24804794, 30661052, 31085000). ClinVar contains an entry for this variant (Variation ID: 180524). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (Invitae) indicates that this missense variant is expected to disrupt SMAD3 function. This variant disrupts the p.Arg287 amino acid residue in SMAD3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21217753, 25644172; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:2
Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies demonstrated that p.(R287Q) resulted in 44% and 20% lower SMAD3 expression in both kidney and liver respectively, compared to the control (Meier et al., 2020); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28185953, 32100971, 30661052, 26221609, 31085000, 30679815, 24804794)
Connective tissue disorder Pathogenic:1
Aneurysm-osteoarthritis syndrome Pathogenic:1
This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PM1,PM2,PM5,PP3.
Loeys-Dietz syndrome Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at